Baidu
map

JACC:动脉斑块体积和形态对心肌灌注量有明显的影响

2018-02-05 MedSci MedSci原创

动脉粥样硬化斑块的特性可能对下游的心肌灌注和冠脉损伤的严重程度有影响。本研究的目的旨在评估斑块的数量和形态对心肌灌注和血流储备分数(FFR)的影响。本研究纳入了208例(男性占63%,平均年龄为58 ± 8.7岁)疑似有冠心病的患者。所有患者通过冠状动脉造影(CTA)对斑块的数量和形态进行评估,并通过PET和侵入性FFR诊断措施对患者心肌灌注和FFR情况进行评估。最终发现有179名患者存在动脉粥样

动脉粥样硬化斑块的特性可能对下游的心肌灌注和冠脉损伤的严重程度有影响。本研究的目的旨在评估斑块的数量和形态对心肌灌注和血流储备分数(FFR)的影响。

本研究纳入了208例(男性占63%,平均年龄为58 ± 8.7岁)疑似有冠心病的患者。所有患者通过冠状动脉造影(CTA)对斑块的数量和形态进行评估,并通过PET和侵入性FFR诊断措施对患者心肌灌注和FFR情况进行评估。最终发现有179名患者存在动脉粥样硬化性斑块,以每条冠脉血管为对象,传统的冠脉斑块指数(包括斑块的长度和体积,最小管腔面积和梗阻率)与心肌血流量减少和FFR的降低呈相关性。此外,斑块的形态,比如部分钙化斑块、阳性重塑(PR)和低衰减斑块对心肌血流量是负面的影响因素。

研究结果显示,阳性重塑和大体积的动脉粥样硬化性斑块对心肌血流灌注和血流储备分数有不利的影响。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1642507, encodeId=f8e1164250e9e, content=<a href='/topic/show?id=8210512940e' target=_blank style='color:#2F92EE;'>#心肌灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51294, encryptionId=8210512940e, topicName=心肌灌注)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=754b22951372, createdName=12498e5fm19(暂无昵称), createdTime=Sat May 19 10:46:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853928, encodeId=91b8185392815, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Feb 15 20:46:00 CST 2018, time=2018-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325695, encodeId=8919132569503, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330071, encodeId=86c613300e1d3, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1642507, encodeId=f8e1164250e9e, content=<a href='/topic/show?id=8210512940e' target=_blank style='color:#2F92EE;'>#心肌灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51294, encryptionId=8210512940e, topicName=心肌灌注)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=754b22951372, createdName=12498e5fm19(暂无昵称), createdTime=Sat May 19 10:46:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853928, encodeId=91b8185392815, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Feb 15 20:46:00 CST 2018, time=2018-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325695, encodeId=8919132569503, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330071, encodeId=86c613300e1d3, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2018-02-15 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1642507, encodeId=f8e1164250e9e, content=<a href='/topic/show?id=8210512940e' target=_blank style='color:#2F92EE;'>#心肌灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51294, encryptionId=8210512940e, topicName=心肌灌注)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=754b22951372, createdName=12498e5fm19(暂无昵称), createdTime=Sat May 19 10:46:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853928, encodeId=91b8185392815, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Feb 15 20:46:00 CST 2018, time=2018-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325695, encodeId=8919132569503, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330071, encodeId=86c613300e1d3, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1642507, encodeId=f8e1164250e9e, content=<a href='/topic/show?id=8210512940e' target=_blank style='color:#2F92EE;'>#心肌灌注#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51294, encryptionId=8210512940e, topicName=心肌灌注)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=754b22951372, createdName=12498e5fm19(暂无昵称), createdTime=Sat May 19 10:46:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853928, encodeId=91b8185392815, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Feb 15 20:46:00 CST 2018, time=2018-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325695, encodeId=8919132569503, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330071, encodeId=86c613300e1d3, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Feb 07 00:46:00 CST 2018, time=2018-02-07, status=1, ipAttribution=)]

相关资讯

Eur Heart J:高心血管风险的糖尿病患者血压和心血管结局分析!

由此可见,对于心血管疾病风险升高的糖尿病患者,即使在对潜在疾病负担进行了广泛调整后,较低的舒张压与亚临床心肌损伤和心肌梗死风险之间仍然存在着持续的联系。

JACC:冠脉对FDG的摄取可作为疾病活跃度的指标

近期的研究表明,血管周围组织的成分,比如血管周围脂肪组织(PVAT)和外膜滋养血管(VV)在心血管疾病的炎症发生过程中起到重要作用。本研究的目的旨在通过PET/CT的方法探究血管痉挛性心绞痛(VSA)患者的冠脉痉挛与血管周围炎症呈相关性。本研究纳入了27名乙酰胆碱诱导的左冠脉痉挛的VSA患者和13名疑似心绞痛但无明确的器质性疾病患者。利用冠脉CT和PET/CT对患者的冠脉PVAT体积和冠脉血管周围

JACC:人胚胎干细胞来源的心脏祖细胞可用于临床治疗

人类胚胎干细胞(hESCs)由于其全能性,可以定向分化为不同组织特异性的细胞。本研究的目的旨在利用人类胚胎干细胞的特性分化出临床级别的心血管祖细胞,并对其应用在严重缺血性左心功能不全患者上的安全性进行评估。本研究共纳入了6名心功能不全患者(平均年龄66.5岁,平均左室射血分数为26%),所有患者均接受了载有平均820万个hESC来源的心血管祖细胞的纤维蛋白补片治疗,主要终点事件是患者术后1年的安全

Int J Nanomed:重磅!研究表明,维生素D3可以帮助治愈或预防心血管损伤

俄亥俄大学科学家进行的一项新研究表明,多一点阳光可能有助于恢复对心血管系统的损害。

BMJ:偏头痛大幅增加主要心脑血管疾病风险

研究认为,偏头痛患者心肌梗死、缺血性卒中、出血性卒中、静脉血栓、房颤或房扑风险增加,偏头痛是重要的心脑血管疾病风险因素

JACC:替卡格雷能明显改善多血管冠脉疾病患者预后

心梗(MI)和多血管冠脉疾病(MVD)患者出现反复性冠脉事件的风险大大增高。本研究的目的旨在评估替卡格雷对PEGASUS-TIMI 54临床试验中的MVD患者的有效性和安全性。有1-3年心梗病史的患者被纳入PEGASUS-TIMI 54临床试验,并根据MVD进行分层。评估替卡格雷(60mg或者90mg)对主要心血管不良事件(MACE,心源性死亡、MI和卒中)、冠脉事件(冠脉源性死亡、MI和支架内血

Baidu
map
Baidu
map
Baidu
map